Hypercalcemia = Total calcium >10.5 mg/dL (ionized >5.5 mg/dL)
| Severity | Level | Symptoms | Urgency |
|---|---|---|---|
| Mild | 10.5-12 | Often asymptomatic | Outpatient evaluation |
| Moderate | 12-14 | Nausea, constipation, confusion | Admit, treat within hours |
| Severe | >14 | Coma, arrhythmias, renal failure | ICU, immediate treatment |
Primary hyperparathyroidism (most common outpatient cause) - Usually from adenoma (85%), rarely parathyroid cancer - Mild, asymptomatic at presentation - PTH elevated or normal (inappropriately normal for high calcium)
Clinical clue: Outpatient, discovered on screening, minimal symptoms
Malignancy with PTHrP (80% of non-PTH cases) - Lung cancer (squamous cell most common) - Breast, ovarian, renal cell, lymphomas - PTH suppressed, PTHrP elevated - Prognosis poor (median survival 2-3 months)
Vitamin D-mediated (granulomatous disease) - Sarcoidosis, tuberculosis, fungal infections - Macrophages make calcitriol (active vitamin D) - 1,25-vitamin D elevated despite PTH suppressed
Thyroid toxicosis, vitamin D intoxication
HYPERCALCEMIA detected (Ca >10.5)
↓
1. CHECK PTH FIRST
├─ PTH HIGH or NORMAL (inappropriately high)
│ └─ Primary hyperparathyroidism or lithium
│ Imaging: US or sestamibi scan for nodules
│
└─ PTH SUPPRESSED (<15)
├─ Check PTHrP
│ └─ Elevated → Malignancy (lung, breast, etc)
│
├─ Check 1,25-vitamin D
│ └─ Elevated → Granulomatous disease
│
└─ Check 25-vitamin D
└─ Elevated → Vitamin D intoxicationZoledronic acid (Zometa) - PREFERRED - Dose: 4 mg IV over 15+ minutes - Efficacy: Normalizes calcium in 88% of patients - Peak effect: 2-4 days - Duration: 3-4 weeks - Monitor: Check creatinine before dose; adjust for renal impairment
Pamidronate - Alternative - Dose: 60-90 mg IV over 2-4 hours - Efficacy: 70% response rate - Slower but similar timeline to zoledronic acid
Key limitation: Bisphosphonate nephrotoxicity risk - Avoid if CrCl <30 mL/min - Use extended infusion times (30-60 minutes) - Monitor creatinine daily × 3 days - Hydrate well before administration
Calcitonin (for urgent rapid lowering only) - Dose: 4-8 IU/kg IV/SC every 6-12 hours - Onset: 4-6 hours - Peak effect: 12-24 hours - Limitation: Tachyphylaxis within 48-72 hours - Use: Bridge therapy only, not maintenance
Prednisone (if granulomatous disease) - Dose: 40-100 mg daily - Inhibits macrophage calcitriol production - Works only for vitamin D-mediated hypercalcemia - Useless for malignancy-related
When to use: - Bisphosphonate-refractory disease - Severe renal impairment (CrCl <30 mL/min) - Patient intolerance to IV bisphosphonates
Advantages: - RANKL inhibitor (blocks bone resorption differently than biphosphonates) - Single subcutaneous dose: 120 mg - Response in 2-4 days - No renal function adjustment needed
Major risk: REBOUND HYPERCALCEMIA after stopping - Can occur 4-9 months later - Severe hypercalcemia possible - Requires long-term management plan (oral bisphosphonates or re-dosing)
| Timeframe | Parameter | Action |
|---|---|---|
| Before treatment | Creatinine, calcium | Baseline; guides bisphosphonate dose |
| During hydration | Daily Ca, Cr, input/output | Adjust rate, watch for overload |
| Days 2-4 | Daily calcium | Monitor for bisphosphonate response |
| After bisphosphonate | Every 3-7 days × 3 weeks | Ensure sustained response |
| Long-term | Monthly (if applicable) | Monitor for relapse |
Standard zoledronic acid 4 mg is FDA-approved, but: - Some clinicians use 2 mg in elderly, renal insufficiency, or mild hypercalcemia - Original trials showed no difference between 4 mg and 8 mg - Lower doses warrant further investigation but may reduce nephrotoxicity
Current practice: Use standard 4 mg with extended infusion (30-60 minutes) rather than dose reduction.
Q1: A 72-year-old with CrCl 25 has malignancy-related hypercalcemia (calcium 13.8, suppressed PTH, elevated PTHrP). How do you treat?
Q2: A patient received denosumab for malignancy-related hypercalcemia. One month later, she’s asymptomatic with normal calcium. What’s the long-term plan?
Q3: A 68-year-old with primary hyperparathyroidism has asymptomatic calcium 11.2. He doesn’t want surgery. What’s your management?
Memory aid: “CHIMPANZEES” = Calcium from Hypercalcemia Involves Malignancy, PTHrP, Adenoma, Nodules, Zoledronic (acid), Excess vitamin D, Endocrine, Sameness (similar labs with different causes)